Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
about
Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapyNeoadjuvant nab-paclitaxel in the treatment of breast cancernab-Paclitaxel for the treatment of breast cancer: an update across treatment settingsNanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis.Phase II study of neoadjuvant anthracycline combined with nanoparticle albumin-bound paclitaxel for human epidermal growth factor receptor 2-negative breast cancer.
P2860
Neoadjuvant triweekly nanoparticle albumin-bound paclitaxel followed by epirubicin and cyclophosphamide for Stage II/III HER2-negative breast cancer: evaluation of efficacy and safety.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@en
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@nl
type
label
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@en
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@nl
prefLabel
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@en
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@nl
P2093
P2860
P356
P1476
Neoadjuvant triweekly nanopart ...... uation of efficacy and safety.
@en
P2093
Akihiko Osaki
Eiko Hirokawa
Hideki Takeuchi
Hiroko Shimada
Ikuko Sugitani
Kazuo Matsuura
Michiko Sugiyama
Shigeto Ueda
Takahiro Hasebe
Takao Takahashi
P2860
P304
P356
10.1093/JJCO/HYV055
P577
2015-05-19T00:00:00Z